Process development of vamicamide (FK176)

Yuki Gosei Kagaku Kyokaishi/Journal of Synthetic Organic Chemistry

Volumn 57, Issue 5, 1999, Pages 415-421

  Kagara, Kooji ^a   Goto, Shunsuke ^a   Ichihara, Masaharu ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Anticholinergic agent; Dichloromethane; Polymorphism; Process development; Reductive amination; Safety; Urinary incontinence

Indexed keywords

EID: 0041718049     PISSN: 00379980     EISSN: None     Source Type: Journal    
DOI: 10.5059/yukigoseikyokaishi.57.415     Document Type: Article

References (10)

1. H. Oyasu, M. Nagano, A. Akahane, M. Tomoi, T. Tada, M. Matsuo, J. Med. Chem., 37, 1378 (1994)
2. Drugs of the Future, 20, 1018 (1995) and the references cited therein.
3. J. Yaozhong, Z. Changyou, W. Shengde, C. Daimo, M. Youan, L. Guilan, Tetrahedron, 44, 5343 (1988)
4. H.E. Katz, M.L. Schilling, J. Org. Chem., 56, 5318 (1991),
5. W. Y. Zhao, Z. T. Huang, Synth. Commun., 23, 591 (1993)
6. G. W. Gribble, D. C. Ferguson, J. Chem. Soc., Chem. Commun., 1975, 535
7. D. A. Evans, K. T. Chapman, E. M. Carreira, J. Am. Chem. Soc., 110, 3560 (1988)
8. A. F. Abdel-Magid, C. Maryanoff, K. G. Carson, Tetrahedron Lett., 31, 5595 (1990)